1. Home
  2. ALLR vs OMH Comparison

ALLR vs OMH Comparison

Compare ALLR & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

HOLD

Current Price

$1.43

Market Cap

25.6M

Sector

Health Care

ML Signal

HOLD

Logo Ohmyhome Limited

OMH

Ohmyhome Limited

HOLD

Current Price

$0.65

Market Cap

24.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLR
OMH
Founded
2004
2015
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
25.6M
24.4M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
ALLR
OMH
Price
$1.43
$0.65
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$9.75
N/A
AVG Volume (30 Days)
219.2K
91.2K
Earning Date
05-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$320,000.00
N/A
Revenue This Year
N/A
$28.40
Revenue Next Year
N/A
$23.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$0.51
52 Week High
$2.35
$1.91

Technical Indicators

Market Signals
Indicator
ALLR
OMH
Relative Strength Index (RSI) 44.65 38.49
Support Level $1.34 N/A
Resistance Level $1.80 $1.09
Average True Range (ATR) 0.14 0.09
MACD -0.03 -0.00
Stochastic Oscillator 2.50 26.75

Price Performance

Historical Comparison
ALLR
OMH

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

Share on Social Networks: